Gene Signal possesses the widest intellectual property portfolio of angiogenesis regulating genes. Gene Signalís discoveries are protected through a comprehensive worldwide patent strategy. All patents are the exclusive property of Gene Signal.
In addition to its R&D discoveries, Gene Signal has also protected its R&D technology platform, GENE-MAAP. R&D processes are protected by a patent covering R&D methodologies and derived experimental conditions related to the identification of genes involved in angiogenesis.
All future R&D technology and product development will continue to be protected by the same worldwide patent strategy.